MHRA approves first oral advanced therapy for Crohn's diseas

The MHRA has approved the first marketing authorisation globally for the use of upadacitinib in Crohn's disease.

Related Keywords

United Kingdom , Great Britain , James Lindsay , Belinda Byrne , Royal London Hospital Barts Health , Regulatory Agency , Professor James Lindsay , Consultant Gastroenterologist , Medical Director , Abbvie United ,